Core Viewpoint - The announcement provides an update on the conversion results and share changes related to the convertible bonds issued by Shanghai Aladdin Biochemical Technology Co., Ltd, highlighting the limited conversion activity and the adjustments in conversion prices over time [2][10]. Convertible Bond Issuance Overview - The company issued 3.874 million convertible bonds with a total value of RMB 38.74 million, starting from April 12, 2022 [3]. - The initial conversion price was set at RMB 63.72 per share [4]. Conversion Status - As of June 30, 2025, a total of RMB 408,000 has been converted into 11,600 shares, representing 0.008209% of the total shares before conversion [2]. - During the period from April 1, 2025, to June 30, 2025, RMB 3,000 was converted into 185 shares, accounting for 0.000131% of the total shares before conversion [10]. - The remaining unconverted bonds amount to RMB 386,985,000, which is 99.892876% of the total issuance [2][10]. Conversion Price Adjustments - The conversion price has undergone several adjustments, with the latest being RMB 13.39 per share effective from June 5, 2025, following the implementation of the 2024 annual profit distribution plan [7][8]. - The conversion price was adjusted downwards multiple times, with the most recent adjustment from RMB 19.89 to RMB 16.17 per share effective from March 26, 2025 [8]. Redemption Status - As of December 10, 2024, the company had canceled RMB 7,000 worth of convertible bonds following a redemption request [9]. Share Capital Changes - The total share capital increased from 277,385,506 shares to 332,602,199 shares due to a capital increase plan, which involved a distribution of shares to existing shareholders [11]. Additional Information - Investors seeking detailed information about the convertible bonds can refer to the company's prospectus published on March 11, 2022 [11].

Core Points - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., has maintained its credit rating for both the company and its convertible bonds at "A+" with a stable outlook [1][4] - The tracking credit rating was conducted by Zhongzheng Pengyuan Credit Rating Co., Ltd. and the results were published on June 24, 2025 [1][2] - The previous credit rating for the company and its bonds was also "A+" with a stable outlook, indicating consistency in the company's financial health [1][4] Summary by Sections - **Company Credit Rating**: The company's main credit rating remains "A+" with a stable outlook, reflecting its solid financial position [1][4] - **Bond Credit Rating**: The credit rating for the "Aladdin Convertible Bonds" is also maintained at "A+" with a stable outlook, indicating reliability for investors [1][4] - **Rating Agency**: The credit rating was performed by Zhongzheng Pengyuan, which conducted a comprehensive analysis of the company's operational status and related industry [1][4]

Core Viewpoint - Shanghai Aladdin Biochemical Technology Co., Ltd. announced its 2024 annual profit distribution and capital reserve transfer plan, which includes a cash dividend of 0.1 yuan per share and a capital reserve transfer of 0.2 shares for every 10 shares held [2][3][6]. Distribution and Capital Increase Plan - The distribution year is set for 2024, with the distribution target being all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the equity registration date [2][5]. - The company plans to distribute a cash dividend of 1.00 yuan for every 10 shares and to increase capital by 2 shares for every 10 shares held, with no bonus shares issued this year [3][6]. Share Capital Structure - As of May 27, 2025, the total share capital is 277,385,506 shares, with 1,302,040 shares in the company's repurchase account, resulting in an effective share capital of 276,083,466 shares for the distribution [6][12]. - The total cash dividend to be distributed amounts to 27,608,346.60 yuan (including tax), and the total number of shares to be increased is 55,216,693, raising the total share capital to 332,602,199 shares post-distribution [6][12]. Tax Implications - For individual shareholders holding unrestricted circulating shares, the actual cash dividend per share is 0.10 yuan, with different tax treatments based on the holding period [9][10]. - For shares held for over one year, the dividend income is exempt from personal income tax, while for shares held for less than one year, the tax treatment varies [10][11]. Convertible Bond Adjustment - The company announced an adjustment to the conversion price of its convertible bonds ("Aladdin Convertible Bonds") due to the profit distribution and capital increase, with the conversion price adjusted from 16.17 yuan to 13.39 yuan per share, effective from June 5, 2025 [19][22][23]. - The adjustment formula considers the cash dividend and the capital increase ratio, ensuring that the bondholders' rights are protected [18][22].

Group 1 - The company will implement a profit distribution plan for the year 2024, which includes a cash dividend of 1.00 yuan (including tax) for every 10 shares and a capital reserve increase of 2 shares for every 10 shares held [1][2] - The profit distribution plan was approved at the company's annual general meeting held on May 15, 2025, and details were disclosed in previous announcements [1][2] - The convertible bonds ("阿拉转债") will have their conversion price adjusted in accordance with the terms outlined in the bond issuance prospectus following the implementation of the profit distribution plan [2] Group 2 - The convertible bonds will be suspended from conversion from May 28, 2025, until the equity registration date, with resumption of conversion on the first trading day after the registration date [2] - Investors wishing to enjoy the profit distribution must convert their bonds by May 27, 2025 [2] - Detailed information regarding the convertible bonds can be found in the company's bond issuance prospectus published on March 11, 2022 [2][3]

Group 1 - The company will announce the implementation of equity distribution and the adjustment of the conversion price for "Aladdin Convertible Bonds" on May 29, 2025 [1] - From May 28, 2025, until the equity distribution registration date, the "Aladdin Convertible Bonds" will suspend conversion, and conversion will resume on the first trading day after the registration date [1] - The profit distribution plan for the year 2024 includes a cash dividend of 1 yuan (before tax) for every 10 shares and a capital reserve increase of 2 shares for every 10 shares [1]

Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., issued a total of 3.874 million convertible bonds, raising a total of RMB 387.4 million, with a net amount of RMB 373.38 million after deducting issuance costs [2][3] - The bonds have a maturity of six years, with an annual interest rate that increases from 0.4% in the first year to 3.0% in the sixth year [3][4] - The initial conversion price for the bonds is set at RMB 63.72 per share, which can be adjusted based on specific corporate actions [5][13] Group 2 - The company has provisions for adjusting the conversion price in case of stock dividends, capital increases, or other corporate actions that affect share capital [6][8] - If the stock price falls below 85% of the conversion price for 15 out of 30 consecutive trading days, the company can propose a downward adjustment of the conversion price, subject to shareholder approval [9][17] - The company has successfully adjusted the conversion price multiple times, with the latest adjustment setting it at RMB 16.17 per share effective from March 26, 2025 [14][18] Group 3 - The company has a credit rating of A+ for the convertible bonds, indicating a stable outlook [12] - The bonds are listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, providing liquidity and visibility to investors [3][5] - The company is committed to maintaining investor rights and will closely monitor the bond's principal and interest repayment situation [18]

Core Viewpoint - Yulong Co., Ltd. has proposed to voluntarily delist from the A-share market, raising questions about the company's underlying quality and future developments [1]. Group 1 - Yulong Co., Ltd. intends to delist through a resolution at the shareholders' meeting, indicating potential issues within the company [1]. - The article expresses skepticism regarding the company's quality, suggesting that it may not be a wise investment choice [1].

Core Viewpoint - The article discusses various convertible bonds and their recent developments, including proposals for adjustments, strong redemptions, and agreements related to restructuring [1]. Group 1: Convertible Bonds Adjustments - The board of directors proposed adjustments for Alatrans Convertible Bond and Shuangliang Convertible Bond [1]. - Guanda Convertible Bond is nearing the bottom of its adjustment range [1]. - The Eagle 19 Convertible Bond and Youzu Convertible Bond have reached the bottom of their adjustment limits [1]. Group 2: Strong Redemptions - Weipai Convertible Bond and Beifang Convertible Bond are undergoing strong redemptions [1]. Group 3: Restructuring Agreements - ST Zhongzhuang has signed a restructuring investment agreement with investors [1]. Group 4: New Stock Subscription - Hengxin Life is offering a subscription for new shares on the ChiNext board [1].

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-014 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于"阿拉转债"预计满足转股价格修正条件的提示 性公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、可转债发行上市概况 经中国证券监督管理委员会证监许可〔2022〕72 号文同意注册，公司于 2022 年 3 月 15 日向不特定对象发行了 387.40 万张可转换公司债券，每张面值 100 元，发行总额 38,740.00 万元。 经上海证券交易所自律监管决定书〔2022〕88 号文同意，公司 38,740.00 万元可转换公司债券于 2022 年 4 月 12 日起在上海证券交易所挂牌交易，债券简 转股期起止日期：2022 年 9 月 21 日至 2028 年 3 月 14 日 本次触发转股价格修正条件的期间从 2025 年 2 月 14 日起算，因公司实 施 2024 年前三季度权 ...